'Multi-cancer' blood tests coming to some GP surgeries in England
'Multi-cancer' blood tests coming to some GP surgeries in England
'Multi-cancer' blood tests coming to some GP surgeries in England
Key points
اہم نکات
मुख्य बातें
- New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial.
- The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner.
- More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests.
- New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial.
- The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner.
- More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests.
- New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial.
- The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner.
- More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests.
New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial. The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner. More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests. Researchers will assess whether the tests are accurate enough for wider NHS use; a positive result does not confirm cancer, and a negative result is not a guaranteed all-clear.
New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial. The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner. More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests. Researchers will assess whether the tests are accurate enough for wider NHS use; a positive result does not confirm cancer, and a negative result is not a guaranteed all-clear.
New blood tests designed to check for several cancers at once will be offered to patients at about 200 GP surgeries in England in a government-funded trial. The STRIDE-RCT trial, led by the University of Birmingham, aims to detect hard-to-diagnose abdominal cancers, including liver, ovarian and pancreatic cancer, much sooner. More than 20,000 patients aged 45 and over with vague symptoms are expected to take part, giving one or two tubes of blood alongside routine tests. Researchers will assess whether the tests are accurate enough for wider NHS use; a positive result does not confirm cancer, and a negative result is not a guaranteed all-clear.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।